chr19-11436155-G-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001289104.2(PRKCSH):āc.38G>Cā(p.Trp13Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000904 in 1,603,430 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. W13R) has been classified as Likely benign.
Frequency
Consequence
NM_001289104.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRKCSH | NM_001289104.2 | c.38G>C | p.Trp13Ser | missense_variant | 2/18 | ENST00000677123.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRKCSH | ENST00000677123.1 | c.38G>C | p.Trp13Ser | missense_variant | 2/18 | NM_001289104.2 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000128 AC: 29AN: 227330Hom.: 0 AF XY: 0.000145 AC XY: 18AN XY: 123840
GnomAD4 exome AF: 0.0000882 AC: 128AN: 1451142Hom.: 0 Cov.: 31 AF XY: 0.0000901 AC XY: 65AN XY: 721666
GnomAD4 genome AF: 0.000112 AC: 17AN: 152288Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74452
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 31, 2023 | The c.38G>C (p.W13S) alteration is located in exon 2 (coding exon 1) of the PRKCSH gene. This alteration results from a G to C substitution at nucleotide position 38, causing the tryptophan (W) at amino acid position 13 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 19, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at